# A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Genentech, Inc. · Condition: Geographic Atrophy

- Company: Genentech, Inc.
- Sector: ophthalmology
- Primary source: https://clinicaltrials.gov/study/NCT05626114

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.